Paraneoplastic hyponatremia
Name | Development Level | Target Family |
---|
Name | Description |
---|---|
mozavaptan | aquaretic agent; vasopressin V2 receptor antagonist; structure given in first source |
TCRDv4.6.9
DrugCentral Indication
DrugCentral
mozavaptan
DrugCentral Indication
DrugCentral
mozavaptan